Could Hepatitis B Vaccine Act as an Adjuvant to Lower Risk and Relapses of Cancer?
Clinical and Experimental Pharmacology and Physiology - United Kingdom
doi 10.1111/1440-1681.13096
Full Text
Open PDFAbstract
Available in full text
Date
May 7, 2019
Authors
Publisher
Wiley